New malaria vaccine trial could stop recurrent fever in its tracks
NCT ID NCT07373301
First seen Jan 31, 2026 · Last updated May 10, 2026 · Updated 17 times
Summary
This study tests an experimental vaccine called PvCS/Montanide ISA-51 to see if it can safely prevent malaria caused by the P. vivax parasite. About 72 healthy adults aged 18-50 will receive three shots over four months, then be exposed to infected mosquitoes under medical supervision. The goal is to find out if the vaccine protects against infection and how well the body's immune system responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Malaria Vaccine and Drug Development Center (MVDC)
Cali, Valle del Cauca Department, 61000, Colombia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.